Trials / Conditions / Moderate to Severe Alzheimer's Disease
Moderate to Severe Alzheimer's Disease
3 registered clinical trials studyying Moderate to Severe Alzheimer's Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) NCT05303701 | Samsung Pharmaceutical Co., Ltd. | Phase 3 |
| Unknown | BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease NCT04229927 | Hyundai Pharmaceutical Co., LTD. | Phase 3 |
| Unknown | Donepezil and Memantine in Moderate to Severe Alzheimer's Disease NCT00866060 | King's College London | Phase 4 |